Robert B. MacArthur
PharmD, MS CEO
Robert B. MacArthur received his PharmD from St. John’s University and MS in Biostatics from Columbia University in New York. From 1988 to 1994 he directed a 60-bed Phase-I unit for LAB Incorporated, and also worked for Sandoz Pharmaceuticals in Drug Safety and Product Labeling.
From 1994 to 2010, he was Director of the Research Pharmacy at Columbia University, directing drug preparation, packaging, dispensing, and distribution for in-hospital trials, ambulatory clinic studies, and multi-centered international trials. From 2010 to 2013 he directed
Bruce Levin, Ph.D.
Bruce Levin, Ph.D., is Professor and Past Chair of the Department of Biostatistics at Columbia University’s Mailman School of Public Health. He has a long-standing interest in statistical methodology for clinical trials, public health, and the law. Using sequential statistical methods, he has published on innovative trial designs, e.g., designs that minimize ethical costs, designs that emphasize the selection paradigm rather than the significance testing paradigm, and novel designs such as the comparative selection trial which combines features of both paradigms. For example, in May of 2009 he gave a short course to the FDA/CDER biostatistics group entitled, “Selection Methods in Clinical Trials.”
Arman Altincatal, Ph.D.
Senior Programmer and Statistician
Arman Altincatal, MS, is a pharmaceutical industry based senior statistician. Mr. Altincatal specializes in statistical methods for clinical trials and observational (large epidemiological cohort) data analyses. He is familiar with a broad range of statistical methods, such as mixed models, repeated measures logistic regression, and survival analysis with time-dependent predictors.
Seamus (John L P) Thompson, Ph.D.
Director of the Statistical Analysis Center (SAC)
Seamus (John L P) Thompson PhD is a Professor of Clinical Biostatistics and Clinical Neurology at Columbia University and Director of the Statistical Analysis Center (SAC) in the Department of Biostatistics. He is an applied statistician specializing in innovative collaborations in prevalent and rare neurological and other disorders. He has, with colleagues, developed an approach to clinical trials and which combines collaboration with eminent clinical investigators, innovative statistical designs, and advanced, customized, flexible, user-friendly data management systems. Seamus has served as Principal Investigator for Statistics and Data Management in major NIH multicenter trials (WARCEF, TNK, QALS, and has participated in industry trials (GAIN, Abciximab, ReoPro) and other collaborations, such as the NIH-funded North American Mitochondrial Research Consortium (NAMDC). He has also served on many trial Data and Safety Monitoring Boards (DSMBs).